Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Global Scenario in Counterfeit Medicines: Threat Assessment, Existing Remedies and Recommendations


Affiliations
1 Pharmacology, Mahatma Gandhi Medical College & Research Institute, Pondicherry-607402, India
2 Forensic Medicine, Vinayaka Mission’s Medical College, Karaikal-609609, India
3 Forensic Medicine, SAIMS, Indore, Madhya Pradesh- 458111, India
     

   Subscribe/Renew Journal


Counterfeit or fake medicines are drugs which are previously expired, fraudulently diluted, adulterated, substituted, completely misrepresented, or sold with a false brand name. They constitute 10% of the global drug market and mostly originate in the developing world, where regulatory and enforcement measures are weakest. Lack of expected clinical benefit, direct harm and emergence of drug resistance can occur due to counterfeit medicines. WHO, along with national and international organizations are taking legislative, regulatory, enforcement, technological and quality assurance initiatives to prevent and detect counterfeit medicines, besides raising awareness about the issue. However, despite making good progress, the threat looms large for the consumer as long as he is not empowered to differentiate between genuine and counterfeit medicines.

Keywords

Counterfeit Medicines, Fake Drugs
Subscription Login to verify subscription
User
Notifications
Font Size


  • World Health Organization. Medicines: Counterfeit medicines. Accessed August 18, 2010.
  • World Health Organization. Media centre. Substandard and Counterfeit Medicines. WHO Fact sheet Nº275, November 2003. Accessed August 14, 2010.
  • World Health Organization. Media centre. Counterfeit Medicines. WHO Fact sheet Nº275, January 2010. Accessed August 14, 2010.
  • Harris J, Stevens P, Morris J. Keeping it Real: Combating the spread of fake drugs in poor countries. International Policy Network May 2009. Accessed July 22, 2010.
  • Cockburn R, Newton PN, Agyarko EK, Akunjili D, White NJ. The Global Threat of Counterfeit Drugs: Why Industry and Governments must communicate the dangers. Plos Med 2(4): e100. doi: 10.1371/journal.pmed.0020100
  • Irish, J. Customs group to fight $200 billion bogus drug industry. Reuters 2010, June 21. < Available at http://www. reuters.com/article/idUSTRE65961U20100610> Accessed August 14, 2010.
  • Sinha, K. Give info on counterfeit drugs, get rewarded. The Times of India 2009, July 23. Accessed August 18, 2010.
  • Bate, Roger. Making a Killing: The deadly implications of the counterfeit drug trade. Washington, DC: The American Enterprise Institute Press, 2008: pp 20-24
  • World Health Organisation. WHO Open Forum on International Medical Products Anti-Counterfeiting Taskforce. Geneva: WHO, 2010 March 26.
  • Tayob, RK. WHO/Big Pharma counterfeit plans receive harsh criticism. TWN Info Service on WTO and Trade issues. Third World Network 2009, January 19. Accessed August 16, 2010.
  • Counterfeit drugs polarize WHO debate. swissinfo.ch. 2010 May 21. . Accessed August 17, 2010.
  • International Pharmaceutical Federation. FIP statement of policy on counterfeit medicines. The Hague, Netherlands: International Pharmaceutical Federation, 2003.
  • The IFPMA ten principles on counterfeit medicines. Accessed August 17, 2010.
  • Pharmaceutical Security Institute. Counterfeit Situation. Accessed June 27, 2010.
  • IDMA –IPC – USP 9th Annual Scientific Meeting 2010 – Report. IDMA bulletin 2010, March 1 - 7; XLI(09). Accessed August 19, 2010.
  • Chatterjee, P. India combats confusion over counterfeit drugs. The Lancet Global Health Network 2010 February 13. Accessed August 5, 2010.
  • Agazzi, I. Laws confuse fake and generic drugs – WHO. Inter Press Service 2010, July 19. Accessed August 19, 2010.
  • Ziance, RJ. Roles for pharmacy in combating counterfeit drugs. Pharmacy Today 2008; 14(6): pp-55-75. Accessed August 4, 2010.
  • Deisingh, AK. Pharmaceutical counterfeiting. The Analyst 2005; 130:271-279. doi: 10.1039/b407759h.
  • Loken M, Chaudhuri A. Counterfeit drugs: Problems and solutions for the Indian Pharmaceutical Industry. Accessed August 19, 2010.
  • World Health Organisation. Be Aware – Tool for Visual inspection of medicines. WHO Department of Quality assurance and safety of medicines. Accessed August 14, 2010.
  • Liang, BA. Counterfeiting and piracy. WIPO/OECD Expert meeting on measurement and statistical issues. Geneva, Switzerland; 2005, October 17-18.
  • Mehta, N, Mahesh, P. Scanner at shops, multi-coloured pills to detect counterfeit medicines. The Economic Times 2009, Oct 9. ET Bureau. Accessed August 17, 2010.

Abstract Views: 202

PDF Views: 0




  • Global Scenario in Counterfeit Medicines: Threat Assessment, Existing Remedies and Recommendations

Abstract Views: 202  |  PDF Views: 0

Authors

K. Lahon
Pharmacology, Mahatma Gandhi Medical College & Research Institute, Pondicherry-607402, India
K. K. Bairagi
Forensic Medicine, Vinayaka Mission’s Medical College, Karaikal-609609, India
R. K. Chaturvedi
Forensic Medicine, SAIMS, Indore, Madhya Pradesh- 458111, India

Abstract


Counterfeit or fake medicines are drugs which are previously expired, fraudulently diluted, adulterated, substituted, completely misrepresented, or sold with a false brand name. They constitute 10% of the global drug market and mostly originate in the developing world, where regulatory and enforcement measures are weakest. Lack of expected clinical benefit, direct harm and emergence of drug resistance can occur due to counterfeit medicines. WHO, along with national and international organizations are taking legislative, regulatory, enforcement, technological and quality assurance initiatives to prevent and detect counterfeit medicines, besides raising awareness about the issue. However, despite making good progress, the threat looms large for the consumer as long as he is not empowered to differentiate between genuine and counterfeit medicines.

Keywords


Counterfeit Medicines, Fake Drugs

References